Medlife International Private Limited

The company commenced operations as an online medicine delivery platform and progressively expanded its services to include online doctor consultations and diagnostic services. All these services were accessible to consumers through a single mobile application. Medlife operated on an inventory-led model, procuring medicines directly from pharmaceutical companies and managing its own fulfilment centers. The business model focused on providing a comprehensive healthcare ecosystem, from digital prescriptions and online consultations to at-home delivery of medicines and wellness products. Revenue was generated from the sale of pharmaceutical and healthcare products, as well as fees for diagnostic and e-consultation services.

Over the years, Medlife achieved significant milestones, including several strategic acquisitions to bolster its service offerings. In November 2018, it acquired the healthcare startup EClinic to enhance its e-consultation capabilities. This was followed by the acquisition of MedLabz in January 2019, a digital healthcare and diagnostics startup, to expand its footprint in the lab testing market. In August 2019, Ananth Narayanan, former CEO of Myntra, joined Medlife as Co-founder and CEO. The company's growth trajectory culminated in its acquisition by PharmEasy in a deal valued at approximately $240 million, which was finalized on May 25, 2021. This merger was the largest consolidation in India's online pharmacy sector at the time, creating the largest healthcare delivery platform in the country. Following the acquisition, Medlife's operations were merged with PharmEasy, and its users were migrated to the PharmEasy platform.